Patents by Inventor Roger Wyburn-Mason

Roger Wyburn-Mason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4426384
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that pyrimidines with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: August 5, 1982
    Date of Patent: January 17, 1984
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4402965
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that furazolidone is effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: August 5, 1982
    Date of Patent: September 6, 1983
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4218449
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that certain nitroimidazole compounds, anti-mycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: March 8, 1979
    Date of Patent: August 19, 1980
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4183941
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that certain nitroimidazole compounds, anti-mycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: August 21, 1978
    Date of Patent: January 15, 1980
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4119723
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that tinidazole and related compounds, antimycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: July 8, 1977
    Date of Patent: October 10, 1978
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason
  • Treatment of rheumatoid arthritis and related diseases
    Patent number: 4073922
    Abstract: It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that clotrimazole bis-phenyl (2-chlorphenyl)-1-imidazolyl-methane! and related compounds, antimycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
    Type: Grant
    Filed: June 29, 1976
    Date of Patent: February 14, 1978
    Assignee: John R. A. Simoons
    Inventor: Roger Wyburn-Mason